Benzinga·2025-09-24 18:18Group 1: Market Overview - U.S. stocks experienced a decline, with the Dow Jones index dropping more than 150 points on Wednesday [1] Group 2: Company-Specific News - Freeport-McMoRan Inc. shares fell 16.4% to $37.94 after the company provided third-quarter sales guidance [1] - The company reported a tragic incident at the Grasberg Block Cave mine, resulting in the fatal injuries of two team members and five others remaining missing [1] - Zhengye Biotechnology Holding Limited shares decreased by 28.2% to $5.02 [4] - YD Bio Ltd shares fell 15% to $17.91 [4] - Harmony Biosciences Holdings, Inc. shares dropped 14.6% to $27.36 after its Phase 3 clinical trial for ZYN002 in Fragile X syndrome did not meet primary endpoints, leading Needham to lower its price target from $48 to $41 [4] - Cohu, Inc. shares declined 12.7% to $19.85 following the announcement of an offering of convertible senior notes [4] - Rigel Pharmaceuticals, Inc. shares fell 12.7% to $29.69 [4] - BGM Group Ltd. shares decreased by 12.2% to $10.31 [4] - Worthington Enterprises, Inc. shares dipped 11.3% to $53.43 after reporting first-quarter results [4] - QMMM Holdings Limited shares fell 11% to $97.00 [4] - Astera Labs, Inc. shares declined 10.6% to $205.65 [4] - Sandisk Corporation shares dipped 8.2% to $97.68 [4]